Zynex Inc (ZYXI) 0.2500 $ZYXI
Zynex Recognized in Top 100 Public Companies by ColoradoBiz
PR Newswire - Fri Jun 17, 7:55AM CDT
Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodiagnostic equipment, cardiac and blood volume monitoring, announces today that ColoradoBiz Magazine has recognized Zynex in Top100 Public Companies in its May 2016 issue.
Zynex Hires Vice President of Operations
PR Newswire - Mon Jun 06, 7:20AM CDT
Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodiagnostic equipment, cardiac and blood volume monitoring, announces today the hire of David "Skip" Mogill as Vice President of Operations. Robert Cozart that had served in this position for over 9 years retired at the end of May this year.
Zynex Reports Electrotherapy Orders for May
PR Newswire - Thu Jun 02, 7:28AM CDT
Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today May orders for the electrotherapy product line.
Zynex Hires Vice President of Finance
PR Newswire - Wed Jun 01, 7:00AM CDT
Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodiagnostic equipment, cardiac and blood volume monitoring, announces today the hire of Rick Luckenbill as Vice President of Finance. Paul Oberman, interim CFO consultant since October 2015 will still be available for the Company on an as-needed basis.
Zynex Announces First Quarter 2016 Results
PR Newswire - Wed May 25, 7:00AM CDT
Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac and blood volume monitoring, announced today its first quarter 2016 financial results.
Zynex Schedules 2016 First Quarter Earnings Release and Webcast
PR Newswire - Mon May 23, 5:58PM CDT
Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2016 first quarter investor webcast on Wednesday, May 25, 2016 at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time).
Zynex Reports Increase in Electrotherapy Orders for March
ACCESSWIRE - Fri Apr 08, 7:00AM CDT
LONE TREE, CO / ACCESSWIRE / April 8, 2016 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today March orders for the electrotherapy product line.
Zynex Announces 2015 Year End Results
ACCESSWIRE - Fri Apr 01, 7:00AM CDT
LONE TREE, CO / ACCESSWIRE / April 1, 2016 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today 2015 year-end financial results.
Zynex Schedules 2015 Year End Earnings Release and Webcast
ACCESSWIRE - Wed Mar 30, 5:41PM CDT
LONE TREE, CO / ACCESSWIRE / March 30, 2016 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2015 year end investor webcast on Friday, April 1, 2016 at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time.)
Zynex Provides Update on January Electrotherapy Orders
ACCESSWIRE - Tue Feb 02, 7:15AM CST
LONE TREE, CO / ACCESSWIRE / February 2, 2016 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodiagnostic equipment, cardiac and blood volume monitoring, announced today January orders for the electrotherapy product line.
Zynex Hires Chief Operating Officer for Growth Initiative
ACCESSWIRE - Wed Jan 27, 7:16AM CST
LONE TREE, CO / ACCESSWIRE / January 27, 2016 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodiagnostic equipment, cardiac and blood volume monitoring, announces today the hire of Michael Hartberger as Chief Operating Officer (COO).
PLT: 44.13 (-0.40)
Zynex Provides Update on Sales Growth
ACCESSWIRE - Tue Jan 05, 7:19AM CST
Electrotherapy Orders Increase by 150% in December
Zynex Appoints Distributor in Taiwan
ACCESSWIRE - Mon Dec 21, 7:30AM CST
LONE TREE, CO / ACCESSWIRE / December 21, 2015 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodiagnostic equipment, cardiac and blood volume monitoring, announced today that it has appointed Deltason Medical as its distributor in Taiwan for its NeuroMove(TM) product line.
Zynex Provides Update on Electrotherapy Orders
ACCESSWIRE - Wed Dec 16, 7:30AM CST
December orders running ahead of forecast
Zynex Announces Third Quarter 2015 Results
ACCESSWIRE - Tue Nov 17, 7:31AM CST
LONE TREE, CO / ACCESSWIRE / November 17, 2015 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac and blood volume monitoring and compound pharmacy, announced today its third quarter 2015 financial results.
Zynex Schedules Third Quarter 2015 Earnings Release and Webcast
ACCESSWIRE - Thu Nov 12, 7:30AM CST
LONE TREE, CO / ACCESSWIRE / November 12, 2015 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac and blood volume monitoring, and compound pharmacy, announced today that it will host the Company's third quarter investor webcast on Tuesday, November 17, 2015 at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time).
Zynex files 510(k) application with US FDA for CM1500 for monitoring blood volume
M2 - Thu Sep 24, 5:50AM CDT
Medical technology company Zynex (Other OTC:ZYXI) said on Wednesday that it has filed an 510(k) application with the Food and Drug Administration pursuant to Section 510(k) of the Food, Drug and Cosmetic Act for clearance of its new CM1500 monitoring device.
Zynex, Inc. Announces FDA Filing for Blood Volume Monitor
ACCESSWIRE - Wed Sep 23, 1:56PM CDT
510(K) Application Filed For CM1500 with the Food and Drug Administration
Zynex Recognized in Top 100 Public Companies by ColoradoBiz
PR Newswire - Fri Jun 17, 7:55AM CDT
Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodiagnostic equipment, cardiac and blood volume monitoring, announces today that ColoradoBiz Magazine has recognized Zynex in Top100 Public Companies in its May 2016 issue.
Zynex Hires Vice President of Operations
PR Newswire - Mon Jun 06, 7:20AM CDT
Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodiagnostic equipment, cardiac and blood volume monitoring, announces today the hire of David "Skip" Mogill as Vice President of Operations. Robert Cozart that had served in this position for over 9 years retired at the end of May this year.
Zynex Reports Electrotherapy Orders for May
PR Newswire - Thu Jun 02, 7:28AM CDT
Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today May orders for the electrotherapy product line.
Zynex Hires Vice President of Finance
PR Newswire - Wed Jun 01, 7:00AM CDT
Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodiagnostic equipment, cardiac and blood volume monitoring, announces today the hire of Rick Luckenbill as Vice President of Finance. Paul Oberman, interim CFO consultant since October 2015 will still be available for the Company on an as-needed basis.
Zynex Announces First Quarter 2016 Results
PR Newswire - Wed May 25, 7:00AM CDT
Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac and blood volume monitoring, announced today its first quarter 2016 financial results.
Zynex Schedules 2016 First Quarter Earnings Release and Webcast
PR Newswire - Mon May 23, 5:58PM CDT
Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2016 first quarter investor webcast on Wednesday, May 25, 2016 at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time).
Zynex Reports Increase in Electrotherapy Orders for March
ACCESSWIRE - Fri Apr 08, 7:00AM CDT
LONE TREE, CO / ACCESSWIRE / April 8, 2016 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today March orders for the electrotherapy product line.
Zynex Announces 2015 Year End Results
ACCESSWIRE - Fri Apr 01, 7:00AM CDT
LONE TREE, CO / ACCESSWIRE / April 1, 2016 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today 2015 year-end financial results.
Zynex Schedules 2015 Year End Earnings Release and Webcast
ACCESSWIRE - Wed Mar 30, 5:41PM CDT
LONE TREE, CO / ACCESSWIRE / March 30, 2016 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2015 year end investor webcast on Friday, April 1, 2016 at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time.)
Zynex Provides Update on January Electrotherapy Orders
ACCESSWIRE - Tue Feb 02, 7:15AM CST
LONE TREE, CO / ACCESSWIRE / February 2, 2016 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodiagnostic equipment, cardiac and blood volume monitoring, announced today January orders for the electrotherapy product line.
Zynex Hires Chief Operating Officer for Growth Initiative
ACCESSWIRE - Wed Jan 27, 7:16AM CST
LONE TREE, CO / ACCESSWIRE / January 27, 2016 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodiagnostic equipment, cardiac and blood volume monitoring, announces today the hire of Michael Hartberger as Chief Operating Officer (COO).
PLT: 44.13 (-0.40)
Zynex Provides Update on Sales Growth
ACCESSWIRE - Tue Jan 05, 7:19AM CST
Electrotherapy Orders Increase by 150% in December
Zynex Appoints Distributor in Taiwan
ACCESSWIRE - Mon Dec 21, 7:30AM CST
LONE TREE, CO / ACCESSWIRE / December 21, 2015 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodiagnostic equipment, cardiac and blood volume monitoring, announced today that it has appointed Deltason Medical as its distributor in Taiwan for its NeuroMove(TM) product line.
Zynex Provides Update on Electrotherapy Orders
ACCESSWIRE - Wed Dec 16, 7:30AM CST
December orders running ahead of forecast
Zynex Announces Third Quarter 2015 Results
ACCESSWIRE - Tue Nov 17, 7:31AM CST
LONE TREE, CO / ACCESSWIRE / November 17, 2015 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac and blood volume monitoring and compound pharmacy, announced today its third quarter 2015 financial results.
Zynex Schedules Third Quarter 2015 Earnings Release and Webcast
ACCESSWIRE - Thu Nov 12, 7:30AM CST
LONE TREE, CO / ACCESSWIRE / November 12, 2015 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac and blood volume monitoring, and compound pharmacy, announced today that it will host the Company's third quarter investor webcast on Tuesday, November 17, 2015 at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time).
Zynex files 510(k) application with US FDA for CM1500 for monitoring blood volume
M2 - Thu Sep 24, 5:50AM CDT
Medical technology company Zynex (Other OTC:ZYXI) said on Wednesday that it has filed an 510(k) application with the Food and Drug Administration pursuant to Section 510(k) of the Food, Drug and Cosmetic Act for clearance of its new CM1500 monitoring device.
Zynex, Inc. Announces FDA Filing for Blood Volume Monitor
ACCESSWIRE - Wed Sep 23, 1:56PM CDT
510(K) Application Filed For CM1500 with the Food and Drug Administration
